Tennessee Execution of Christa Pike Fails After Two Lethal Injections, Inmate Hospitalized

Tennessee's attempt to execute convicted murderer Christa Pike by lethal injection collapsed dramatically on Wednesday evening when the 50-year-old survived two doses of the drug pentobarbital, prompting authorities to rush her to an off-site hospital for emergency medical care.

Pike had been scheduled to die at a state facility, but her legal team reported that the two syringes administered failed to stop her heartbeat. According to her lawyers, she could still be heard snoring after the second injection, indicating that she remained alive despite the state's efforts.

The US Supreme Court had cleared the way for the execution at the eleventh hour, allowing it to proceed after a protracted legal battle that had already drawn widespread attention. The last-minute judicial authorization meant that the procedure went ahead late on Wednesday local time.

The Tennessee Department of Correction has defended its execution protocol, stating that "the protocol does not allow for additional procedures beyond what was carried out this evening." The department has not explained why the dosage proved insufficient to cause death, leaving key questions unanswered.

Pike was sentenced to death in 1996 for the torture and murder of 19-year-old Colleen Slemmer, a killing carried out alongside her then-boyfriend, Tadaryl Shipp. Shipp was 17 at the time of the crime and was spared the death penalty under state law; he remains in prison.

Following the failed execution, Pike was transferred to a medical facility where one of her lawyers said she was "being provided life-saving measures." Her condition remained unclear as of Thursday morning, and no official update on her health had been released.

Dr Joel Zivot, a professor at Emory University School of Medicine who said he had been retained by Pike's legal team as a medical expert, told the BBC that she likely never reached a sufficient blood level of pentobarbital to trigger apnoea and cardiovascular failure. He also warned that "it's very possible that as a consequence of the delay of the beginning of resuscitation she will have a brain injury."

Tennessee Governor Bill Lee has ordered a third-party review of what went wrong and announced that the state's last remaining execution of the year will not proceed as scheduled. The decision signals growing scrutiny of how the state carries out capital punishment.

May Martinez, the mother of victim Colleen Slemmer, had pushed for Pike's execution to be carried out. Reacting to the events, she told NBC News that the situation had been "a mess," reflecting the frustration and distress felt by the victim's family.

Opponents of the death penalty responded swiftly. Maya Foa, chief executive of the international legal organisation Reprieve, said: "We cannot know exactly what went wrong, because so much happened behind a curtain – lethal injection relies on secrecy at every stage, to hide the violence of the state taking a human life."

Pentobarbital, the drug used in the attempt, is a powerful sedative that suppresses the nervous system. While doctors sometimes use it to treat certain conditions, in high doses it is employed in lethal injections to cause death.

Its use has come under renewed scrutiny since a US federal government review conducted under President Joe Biden raised concerns about the drug's potential to cause "unnecessary pain and suffering." The federal government subsequently banned its use in federal executions, though that decision did not bind individual states such as Tennessee, which set their own methods.

Pike's legal team has alleged that the pentobarbital used in her execution was "degraded." Drugs can lose potency for various reasons, including age beyond their use-by date. The Tennessee Department of Correction did not directly address that allegation but issued a broader defence, saying: "The lethal injection chemical in the protocol has consistently been effective."

Authorities have not said whether they will attempt to execute Pike a second time. There is historical precedent for states making further attempts to carry out a death sentence after an initial failure, though such decisions typically provoke intense legal and ethical debate.

The failed execution is not the first problem Tennessee has encountered this year. In May, the execution of Tony Carruthers, convicted of kidnapping and murdering three people in 1994, was postponed after staff could not find a vein to administer the lethal injection. Governor Lee granted him a one-year reprieve.

Nationwide, botched executions continue to raise alarm. According to the Death Penalty Information Center, more than a third of executions carried out in the US in 2022 were botched or highly problematic. The organisation provides statistics and research on capital punishment but does not take a position on its morality.

The case has renewed attention on the secrecy surrounding lethal injection procedures and the suffering that can result when executions do not go according to plan. For death penalty opponents, the events in Tennessee underscore their concerns, while supporters of capital punishment face fresh questions about the reliability of the method.

As Pike remains hospitalized and the governor's review gets underway, the state must decide how to proceed. Whether Tennessee will seek to carry out another execution attempt, and what the review will conclude about the drug and the protocol, remain open questions with significant implications for the future of capital punishment in the state.